Novo CEO pressed by Senate to cut charges of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers in regards to the list prices of Wegovy and copyright should they pledge to keep the medicines on their formularies. The https://buschpeachcalories61505.blog-gold.com/37848804/top-latest-five-healthcare-news-urban-news